Full Text
Full text is available in PDF
Background:
In Iran, the number of injecting drug users (IDUs) has increased in recent years. The rates of hepatitis C virus (HCV) and hepatitis B virus (HBV) infections among IDUs are reportedly high.
Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran
Author(s):
Masoumeh Amin-Esmaeili1, Masoumeh Amin-Esmaeili1, 
Afarin Rahimi-Movaghar
1,*, Afarin Rahimi-Movaghar2,*, Emran M. Razaghi1, Emran M. Razaghi2, Ahmad Reza Baghestani1, Ahmad Reza Baghestani3, Siavash Jafari3, Siavash Jafari41Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, IR Iran
2Psychiatry Department, Tehran University of Medical Sciences, Tehran, IR Iran
3Islamic Azad University, South Tehran Branch, Tehran, IR Iran
4Faculty of Medicine, School of Population and Public Health, The University of British Columbia, Vancouver, Canada
Corresponding Authors:
Published online:Dec 31, 2011
Article type:Research Article
Received:Oct 08, 2011
Accepted:Jan 02, 2012
How to Cite:Masoumeh Amin-EsmaeiliMasoumeh Amin-EsmaeiliAfarin Rahimi-MovagharAfarin Rahimi-MovagharEmran M. RazaghiEmran M. RazaghiAhmad Reza BaghestaniAhmad Reza BaghestaniSiavash JafariSiavash Jafariet al.Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran.Hepat Mon.12(1):23-31.https://doi.org/10.5812/kowsar.1735143X.806.
Abstract
Objectives:
The purpose of this study was to assess factors correlated with HCV and HBV infections among IDUs in Tehran.
Patients and Methods:
A cross-sectional study included 899 IDUs recruited from the community, drug treatment centers, and drop-in-centers. The study involved interviews conducted using an adapted version of the WHO Drug Injection Study Phase II (Version 2b) questionnaire and blood testing for the HCV antibody, hepatitis B surface antigen, and hepatitis B core antibody. A logistic regression model was used to identify independent factors correlated with HCV and HBV infections.
Results:
HCV infection was found to be primarily associated with female gender [odds ratio (OR) 5.0, 95% confidence interval (CI) 2.0-10.0)], unmarried status (OR 2.9, 95% CI 1.9-4.4), drug use for more than 10 years (OR 2.7, 95% CI 1.8-3.9), drug injection frequency of more than once per day (OR 2.6, 95% CI 1.6-4.2), history of imprisonment (OR 2.5, 95% CI 1.6-4.0)], and a history of shared injection needles in prison (OR 2.3, 95% CI 1.5-3.6). HBV infection was mainly correlated with a history of imprisonment (OR 1.9, 95% CI 1.4-2.7) and drug use for more than 10 years (OR 1.4, 95% CI 1.1-1.9).
Conclusions:
Because a considerable number of IDUs in Iran are receiving reduction services, tailoring services for prevention of hepatitis infection are necessary.
Copyright
© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
comments
Leave a comment here
Crossmark
Checking
Comments
Number of Comments:0Cited by
Purchasing Reprints
- Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations
Author(s):
- Masoumeh Amin-Esmaeili:[PubMed][Scholar]
- Masoumeh Amin-Esmaeili:[PubMed][Scholar]
- Afarin Rahimi-Movaghar:[PubMed][Scholar]
- Afarin Rahimi-Movaghar:[PubMed][Scholar]
- Emran Razaghi:[PubMed][Scholar]
- Emran M. Razaghi:[PubMed][Scholar]
- Ahmad Baghestani:[PubMed][Scholar]
- Ahmad Reza Baghestani:[PubMed][Scholar]
- Siavash Jafari:[PubMed][Scholar]
- Siavash Jafari:[PubMed][Scholar]
Related Articles